BioStem Technologies, Inc. revenue for the last year amounted to 16.69 M USD, the most of which — 14.54 M USD — came from its highest performing source at the moment, Advance Wound Care, the year earlier bringing 4.04 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought BioStem Technologies, Inc. 16.69 M USD, and the year before that — 6.88 M USD.